Institutional & Family Asset Management’s NovoCure NVCR Stock Holding History

Institutional & Family Asset Management’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$5.65K	Hold	330	–	–	﹤0.01%	483
2024 Q1	$5.16K	Hold	330	–	–	﹤0.01%	491
2023 Q4	$4.93K	Hold	330	–	–	﹤0.01%	483
2023 Q3	$5.33K	Hold	330	–	–	﹤0.01%	452
2023 Q2	$13.7K	Buy	+330	New	+$20.5K	﹤0.01%	352
2021 Q4	–	Sell	-1,000	Closed	-$116K	–	886
2021 Q3	$116K	Buy	1,000 +500	+100%	+$75.6K	0.02%	224
2021 Q2	$111K	Hold	500	–	–	0.02%	226
2021 Q1	$66K	Sell	500 -500	-50%	-$79.1K	0.01%	318
2020 Q4	$173K	Sell	1,000 -35	-3%	-$4.79K	0.04%	196
2020 Q3	$115K	Sell	1,035 -20	-2%	-$1.6K	0.03%	219
2020 Q2	$63K	Buy	1,055 +529	+101%	+$34.8K	0.01%	285
2020 Q1	$35K	Buy	526 +500	+1,923%	+$39.5K	0.01%	303
2019 Q4	$2K	Hold	26	–	–	﹤0.01%	750
2019 Q3	$2K	Buy	+26	New	+$2.08K	﹤0.01%	713

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Institutional & Family Asset Management's NVCR Position: Q2 2024 in Review

Institutional & Family Asset Management held its NovoCure (NVCR) position steady in Q2 2024 at 330 shares worth $5.65K. The position accounts for ﹤0.01% of the portfolio, ranked #483.

Institutional & Family Asset Management first reported a position in NVCR in Q3 2019 and has held it in 14 quarters since. The position peaked at $173K in Q4 2020. 237 funds tracked by Wall St. Rank hold NVCR as of Q2 2024.

Institutional & Family Asset Management held 330 shares of NovoCure worth $5.65K as of Q2 2024.
Institutional & Family Asset Management left its NovoCure share count unchanged in Q2 2024.
NovoCure made up ﹤0.01% of Institutional & Family Asset Management's portfolio in Q2 2024, its #483 holding.
Institutional & Family Asset Management first reported a position in NovoCure in Q3 2019 and has held it in 14 quarters since.
Institutional & Family Asset Management's NovoCure position peaked at $173K in Q4 2020.
237 funds tracked by Wall St. Rank held NovoCure as of Q2 2024.

Based on Institutional & Family Asset Management's 13F filing for Q2 2024, filed 5 Jul 2024.